OB/GYN Clinical Alert – March 1, 2009
March 1, 2009
View Issues
-
Recognizing Placenta Accreta Before Delivery
Placenta accreta can represent a real clinical conundrum, especially if it is unrecognized before delivery. -
Discontinuing Bisphosphonate Therapy
Curtis and colleagues from the University of Alabama at Birmingham measured the rate of hip fracture among women who discontinued bisphosphonate therapy compared with women who remained on treatment. -
Visual Estimation and Calculated Blood Loss After Delivery
A few studies have suggested that we tend to underestimate blood loss during deliveries and cesarean sections. A group from Louisiana State University has addressed this issue again in a very clever way. -
Hormone Therapy Improves Quality of Life in Older Women
The Women's Iinternational Study of Long Duration Oestrogen after the Menopause (WISDOM) trial was a randomized, controlled trial in the United Kingdom, Australia, and New Zealand, of 3721 women aged 50-69 treated with either combined 0.625 mg conjugated estrogens and 2.5/5.0 mg medroxyprogesterone, or placebo. The original plan was to randomize 22,300 women to the study that would last 10 years. -
Special Feature: On the Origin of Ovarian Cancer Is It the Ovary?
One of the most common and poignant questions an ovarian cancer patient asks upon learning of her diagnosis is, "How did I get this? -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Warning Regarding Topical Anesthetics
In this issue: FDA warning on topical anesthetics; antipsychotics increase sudden cardiac death; the step up vs step down debate; treating pain, fatigue, mood, and sleep in fibromyalgia; FDA Actions.